Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum.
Zimmer Biomet’s $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
Where Today's News Shapes Tomorrow
